Curry Brown, MBA
About Curry Brown, MBA
Curry Brown, MBA, is the Sr Group Manager of Upstream Marketing & Strategy at Boston Scientific, where he leads the New Therapies Accelerator and directs the long-term portfolio strategy for Cancer Therapies.
Current Position at Boston Scientific
Curry Brown is currently serving as the Sr Group Manager of Upstream Marketing & Strategy at Boston Scientific since 2020. In this role, he leads the New Therapies Accelerator and is responsible for directing the long-term portfolio strategy for Cancer Therapies. He collaborates with various departments such as Health Economics, Regulatory, and Investor Relations to advance organizational goals. Curry reports directly to the Vice President of Upstream Marketing & Portfolio Strategy.
Previous Experience at BTG plc
Before joining Boston Scientific, Curry Brown held multiple positions at BTG plc. From 2018 to 2020, he was the Global Director of Strategy & Upstream Marketing. Prior to that, he served as the Regional Sales Manager-Interventional Oncology from 2015 to 2018 in the Charlotte, North Carolina area. He also held the position of Territory Sales Manager-Interventional Oncology from 2013 to 2015.
Experience at Hitachi Medical Systems America
Curry Brown worked at Hitachi Medical Systems America as a Sales Representative from 2008 to 2013. During his five-year tenure, he was based in the Charlotte, North Carolina area.
Early Career Roles
Earlier in his career, Curry Brown held various sales positions. He worked at Brainlab as an Area Sales Representative from 2006 to 2008, and at AT&T in Solution Sales from 2002 to 2006.
Educational Background
Curry Brown possesses a strong educational foundation. He earned a BS in Finance & Spanish with a Minor in Economics from The University of Alabama, where he studied from 1998 to 2002. Additionally, he holds an MBA in Marketing & Health Economics from Mercer University Stetson-Hatcher School of Business.